Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 11, 2013 - Issue 10
Submit an article Journal homepage
90
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Developments in therapy and diagnosis of yaws and future prospects

Oriol MitjàBarcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain;Lihir Medical Centre-International SOS, Lihir Island, Papua New GuineaCorrespondence[email protected]
&
Quique BassatBarcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain
Pages 1115-1121 | Published online: 10 Jan 2014

References

  • Mitjà O, Asiedu K, Mabey D. Yaws. Lancet 381, 763–773 (2013).
  • Widy Wirski R. Surveillance and control of resurgent yaws in the African region. Rev. Infect. Dis. 7, 227–232 (1985).
  • Zahra A. Yaws in Southeast Asia: An overview. Rev. Infect. Dis. 7, 245–250 (1985).
  • WHO. Eradication of yaws - the Morges Strategy. WHO Wkly. Epidemiol. Rec. 87, 189–194 (2012).
  • Lukehart Sa, Fohn MJ, Baker-Zander SA. Efficacy of azithromycin for therapy of active syphilis in the rabbit model. J. Antimicrob. Chemother. 25, 91–99 (1999).
  • Rein MF. Biopharmacology of syphilotherapy. J. Am. Vener. Dis. Assoc. 3, 109–127 (1976).
  • Norris S, COx D, Winstock G. Biology of Treponema pallidum: correlation of functional activities with genome sequence data. J. Mol. Microb. Biotech. 3, 37–62 (2001).
  • Stamm L, Stapleton J, Bassford P. In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidum. Antimicrob. Agents Chemother. 32, 164–169 (1988).
  • Eagle H, Fleishman R. The relative antisyphilitic activity of penicillins F, G, K, and X and of bacitracin, based on the amounts required to abort early syphilitic infections in rabbits. J. Bacteriol. 55, 341–346 (1948).
  • Alder J, Jarvis K, Mitten M, Shipkowitz NL, Gupta P. Clarithromycin therapy of experimental Treponema pallidum infections in hamster. Antimicrob. Agents Chemother. 37, 864 (1993).
  • Lukehart SA, Baker-Zander SA. Roxithromycin (RU 965): effective therapy for experimental syphilis infection in rabbits. Antimicrob. Agents Chemother. 31, 187–190 (1987).
  • Leschine SB, Canale-Parola E. Rifampin resistant RNA polymerase in spirochetes. FEMS Microbiol. Lett. 35, 199–204 (1986).
  • Une T, Nakajima R, Otani T, Katami K, Osada Y, Otani M. Lack of effectiveness of ofloxacin against experimental syphilis in rabbits. Arzneimittelforschung 37, 1048–1051 (1987).
  • Veller-Fornasa C, Tarantello M, Cipriani R, Guerra L, Peserico A. Effect of ofloxacin on Treponema pallidum in incubating experimental syphilis. Genitourin. Med. 63, 214 (1987).
  • WHO Scientific Group. Treponemal infections. Technical Report Series No. 674. Geneva: World Health Organization (1982).
  • Standard treatment for common illnesses of children in Papua New Guinea, PNG, 2011.
  • Rein CR. Treatment of yaws in the Haitian peasant. J. Natl Med. Ass. 41, 60–65 (1941).
  • Li HY. Serological study of yaws in Java. Bull. World Health Organ. 12, 905–943 (1955).
  • Scolnik D, Aronson L, Lovinsky R et al. Efficacy of a targeted, oral penicillin-based yaws control program among children living in rural South America. Clin. Infect. Dis. 36, 1232–1238 (2003).
  • Johnson RC, Bey RF, Wolgamot SJ. Comparison of the activities of ceftriaxone and penicillin G against experimentally induced syphilis in rabbits. Antimicrob. Agents Chemother. 21, 984–989 (1982)
  • Steele RW. Ceftriaxone therapy of meningitis and serious infections. Am. J. Med. 77, 50–53 (1984)
  • Baker-Zander SA, Lukehart SA. Efficacy of cefmetazole in the treatment of active syphilis in the rabbit. Antimicrob. Agents Chemother. 33, 1465–1469 (1989).
  • Fitzgerald TJ. Effects of cefetamet (Ro 15-8074) on Treponema pallidum and experimental syphilis. Antimicrob. Agents Chemother. 36, 598–602 (1992).
  • Ampofo O, Findlay GM. Aureomycin in the treatment of yaws and tropical ulcer in Africa. Nature 165, 398–399 (1950).
  • Loughlin EH, Joseph A, Schaeffer K. Aureomycin in the treatment of yaws. Am. J. Trop. Med. Hyg. 31, 20–23 (1951).
  • Hill KR. The modern treatment of frambesia (yaws). West Indian Med. J. 1, 81–92 (1951).
  • Gulati RK. Doxycycline in children?--the unanswered question. Pediatr. Dermatol. 27, 419 (2010).
  • Antal GM, Lukehart SA, Meheus AZ. The endemic treponematoses. Microbes Infect. 4, 83–94 (2002).
  • Mitjà O, Hays R, Ipai A et al. Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial. Lancet 379, 342–347 (2012).
  • Evans JR, Solomon AW. Antibiotics for trachoma. Cochrane Database Syst. Rev. 16, CD001860 (2011).
  • Ray WA, Murray KT, Hall K et al. Azithromycin and the risk of cardiovascular death. N. Engl. J. Med. 366, 1881–1890 (2012).
  • Svanström H, Pasternak B, Hviid A. Use of azithromycin and death from cardiovascular causes. N Engl. J. Med. 368(18): 1704–1712 (2013).
  • Porco TC, Gebre T, Ayele B et al. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 302, 962–968 (2009).
  • Keenan JD, Emerson PM, Gaynor BD et al. Adult mortality in a randomized trial of mass azithromycin for trachoma. JAMA Intern. Med. 173(9): 821–823 (2013).
  • Hook EW3rd, Martin DH, Stephens J, Smith BS, Smith K. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex. Transm. Dis. 29, 486–490 (2002).
  • Riedner G, Rusizoka M, Todd J et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N. Engl. J. Med. 353, 1236–1244 (2005).
  • Lukehart SA, Fohn MJ, Baker-Zander SA. Efficacy of azithromycin for therapy of active syphilis in the rabbit model. J. Antimicrob. Chemother. 25, 91–99 (1990).
  • Kiddugavu MG, Kiwanuka N, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F. Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex. Transm. Dis. 32, 1–6 (2005).
  • CDC. Azithromycin treatment failures in syphilis infections— San Francisco, California, 2002–2003. Morb. Mortal. Wkly. Rep. 53, 197–198 (2004).
  • Stamm LV, Bergen HL. A point mutation associated with bacterial macrolide resistance ispresent in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob. Agents Chemother. 44, 806–807 (2000).
  • Matejková P, Flasarová M, Zákoucká H et al. Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. J. Med. Microbiol. 58, 832–836 (2009).
  • Lukehart SA, Godornes C, Molini BJ et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N. Engl J. Med. 351, 154–158 (2004).
  • Martin I, Gu W, Yang Y, Tsang RS. Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. Clin. Infect. Dis. 49, 515–521 (2009)
  • Martin IE, Tang R, Sutherland K et al. Molecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs. J. Clin. Microbiol. 47, 1668–1673 (2009).
  • Marra CM, Colina AP, Godornes C, Tantalo L, Puray M, Centurion-Lara A, Lukehart S. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. J. Infect. Dis. 194, 1771–1773 (2006).
  • Van Damme K, Behets F, Ravelomanana N et al. Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar. Sex. Transm. Dis. 36, 775–776 (2009).
  • Mabey D. Oral azithromycin for treatment of yaws. Lancet 379, 295–297 (2012).
  • Mitja O, Hays R, Lenngei F et al. Challenges in recognition and diagnosis of yaws in children in Papua new Guinea. Am. J. Trop. Med. Hyg. 85, 113–116 (2011).
  • Herring AJ, Ballard RC, Pope V, et al. A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera. Sex. Transm. Infect. 82, 7–12 (2006).
  • Castro AR, Esfandiari J, Kumar S et al. Novel point-of-care test for simultaneous detection of nontreponemal and treponemal antibodies in patients with syphilis. J. Clin. Microbiol. 48, 4615–4619 (2010).
  • Yin YP, Chen XS, Wei WH. A dual point-of-care test shows good performance in simultaneously detecting nontreponemal and treponemal antibodies in patients with syphilis - A multi-site evaluation study in China. Clin. Infect. Dis. 56, 659–665 (2013).
  • Medina R. Evolutive serological responses in patients with buba. Arch. Venez. Med. Trop. Parasitol. Med. 3, 290–297 (1959).
  • Mitjà O, Hays R, Ipai A et al. Outcome predictors in treatment of yaws. Emerg. Infect. Dis. 17, 1083–1085 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.